|
EIF2C2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.776000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.536200E-03 |
| Normal-vs-Stage2 |
3.979800E-02 |
| Normal-vs-Stage3 |
4.682600E-01 |
| Normal-vs-Stage4 |
9.194800E-01 |
| Stage1-vs-Stage2 |
7.630200E-01 |
| Stage1-vs-Stage3 |
8.443700E-02 |
| Stage1-vs-Stage4 |
3.187800E-01 |
| Stage2-vs-Stage3 |
3.523400E-01 |
| Stage2-vs-Stage4 |
3.894000E-01 |
| Stage3-vs-Stage4 |
6.201200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.823500E-03 |
| Normal-vs-AfricanAmerican |
2.358100E-03 |
| Normal-vs-Asian |
2.582500E-02 |
| Caucasian-vs-AfricanAmerican |
4.353000E-01 |
| Caucasian-vs-Asian |
4.720200E-01 |
| AfricanAmerican-vs-Asian |
5.167400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.48779999999704E-05 |
| Normal-vs-Female |
7.849800E-01 |
| Male-vs-Female |
3.226500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.858000E-02 |
| Normal-vs-Extreme_Weight |
3.58510000000312E-05 |
| Normal-vs-Obese |
5.235400E-01 |
| Normal-vs-Extreme_Obese |
7.34789999956575E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.753590E-01 |
| Normal_Weight-vs-Obese |
2.599000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.145600E-02 |
| Extreme_Weight-vs-Obese |
3.355600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.788000E-02 |
| Obese-vs-Extreme_Obese |
6.26059999999651E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.182600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.236500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.92499999999552E-05 |
| Normal-vs-Age(81-100Yrs) |
1.663280E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.999170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.878500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.263800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.406360E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.369800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.507800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.758100E-04 |
| Normal-VS-Type2 PRCC |
1.645070E-04 |
| Normal-VS-KIRP CIMP |
4.886300E-02 |
| Normal-VS-Unclassified PRCC |
1.357610E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.289800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.099730E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.668400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.277860E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.816850E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.423600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58910000000101E-05 |
| Normal-vs-N1 |
5.444000E-01 |
| Normal-vs-N2 |
5.287600E-01 |
| N0-vs-N1 |
9.038800E-03 |
| N0-vs-N2 |
3.141000E-01 |
| N1-vs-N2 |
3.930000E-01 |
|
|
